CORC

在结果中检索

CORC

浏览/检索结果: 共12条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Structure of the catalytically active copper-ceria interfacial perimeter 期刊论文
NATURE CATALYSIS, 2019, 卷号: 2, 期号: 4, 页码: 334-341
作者:  Sehested, Jens;  Chen, Aling;  Yu, Xiaojuan;  Zhou, Yan;  Miao, Shu
收藏  |  浏览/下载：85/0  |  提交时间：2019/06/20
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 期刊论文
JOURNAL OF HEPATOLOGY, 2019, 卷号: 70
作者:  Gong, Guozhong;  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun
收藏  |  浏览/下载：58/0  |  提交时间：2019/12/05
Sofosbuvir-velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial 期刊论文
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 卷号: 4, 期号: 2
作者:  Li, Jun;  Jia, Jidong;  Hou, Jin Lin;  Mohamed, Rosmawati;  Duan, Zhongping
收藏  |  浏览/下载：44/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：46/0  |  提交时间：2019/12/05
On-treatment changes of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein are associated with the regression of liver fibrosis in chronic hepatitis B patients on interferon alpha add-on therapy 期刊论文
JOURNAL OF MEDICAL VIROLOGY, 2019, 卷号: 91, 期号: 8
作者:  Liu, Tianhui;  Sun, Yameng;  Zhou, Jialing;  Yang, Fang;  Zou, Xia
收藏  |  浏览/下载：100/0  |  提交时间：2019/12/05
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial 期刊论文
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 卷号: 73, 期号: 4
作者:  Szarek, Michael;  White, Harvey D.;  Schwartz, Gregory G.;  Alings, Marco;  Bhatt, Deepak L.
收藏  |  浏览/下载：135/0  |  提交时间：2019/12/05
pPolyHb protects myocardial H9C2 cells against ischemia-reperfusion injury by regulating the Pink1-Parkin-mediated mitochondrial autophagy pathway 期刊论文
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2019, 卷号: 47, 页码: 1248-1255
作者:  Zhu, Wenjin;  Liu, Fang;  Wang, Li;  Yang, Bo;  Bai, Yuwei
收藏  |  浏览/下载：24/0  |  提交时间：2019/11/19
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：37/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：39/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace